Aurelia de Pauw
Corporate Officer/Principal presso TETRA BIO-PHARMA INC.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Guy Chamberland | M | - |
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | 8 anni |
| Steeve Néron | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | 6 anni |
| Damon C. Smith | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| H. Norton | M | 63 | 4 anni | |
| Sylvain Guénette | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Natalie Leroux | F | - | - | |
| Mark A. Beaudet | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Catherine Auld | F | - | 3 anni | |
| Dale MacCandlish-Weil | F | 68 | 4 anni | |
| John Kim | M | - | 3 anni | |
| Ofer Yifrach-Stav | M | - | 6 anni | |
| Sonia Gervais | F | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Dania Scott | F | - | 4 anni | |
| Derek Theriault | M | - | - | |
| Michael Olders | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Benoit Chotard | M | 59 | 1 anni | |
| Gregory Drohan | M | - | 2 anni | |
| Bill Cheliak | M | - | 4 anni | |
| Carl Merton | M | - | 4 anni | |
| Sabino di Paola | M | 46 | 5 anni | |
| Robert J. Bechard | M | - | 3 anni | |
| Leslie Auld | F | - | - | |
| Sylvain Chrétien | M | 59 | - | |
| Bernard Lessard | M | - | 2 anni | |
| Jean-Francois Boily | M | - | 1 anni | |
| Graham Wood | M | - | 1 anni | |
| Jean Diercxsens | M | 36 |
Université de Namur ASBL
| 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Canada | 26 | 96.30% |
| Belgio | 1 | 3.70% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Aurelia de Pauw
- Contatti personali
